Cite
Targeting FOSB with a cationic antimicrobial peptide, TP4, for treatment of triple-negative breast cancer
MLA
Chang-Jer Wu, et al. “Targeting FOSB with a Cationic Antimicrobial Peptide, TP4, for Treatment of Triple-Negative Breast Cancer.” Oncotarget, vol. 7, May 2016, pp. 40329–47. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....30587ab8285cc887aa4a992618448a44&authtype=sso&custid=ns315887.
APA
Chang-Jer Wu, Yi-Chun Chen, Chen-Hung Ting, & Jyh-Yih Chen. (2016). Targeting FOSB with a cationic antimicrobial peptide, TP4, for treatment of triple-negative breast cancer. Oncotarget, 7, 40329–40347.
Chicago
Chang-Jer Wu, Yi-Chun Chen, Chen-Hung Ting, and Jyh-Yih Chen. 2016. “Targeting FOSB with a Cationic Antimicrobial Peptide, TP4, for Treatment of Triple-Negative Breast Cancer.” Oncotarget 7 (May): 40329–47. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....30587ab8285cc887aa4a992618448a44&authtype=sso&custid=ns315887.